NCT00216437 2007-11-12Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or CholangiocarcinomaJames A. Haley Veterans Administration HospitalPhase 1 Terminated30 enrolled